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Summary
Objective: To investigate cartilage response to ﬁbroblast growth factor-2 (FGF-2) with increasing age in vivo, we examined the effect of FGF-2
on partial thickness defects of immature and mature rabbits.
Design: Sixty-nine Japanese white rabbits (34 immature rabbits, 35 mature rabbits) were examined. We made experimental partial thickness
defects in articular cartilage of the knees. Then, we injected FGF-2 into the knees eight times, immediately after surgery and every 2 days for 2
weeks. A single dose of FGF-2 was 10 ng/0.1 ml or 100 ng/0.1 ml. In the control group, 0.1 ml saline was injected on the same time schedule.
The rabbits were sacriﬁced at intervals following surgery that ranged from 2 to 48 weeks. The specimens were stained with toluidine blue and
examined microscopically. We used a modiﬁed semiquantitative scale for evaluating the histological appearance of repair.
Results: In immature rabbits, the cartilage repair in the FGF-2 (100 ng)-treated group was signiﬁcantly better than that of the other groups. The
defects were almost completely repaired with chondrocytes that showed a round to polygonal morphology, and large amounts of extracellular
matrix with intense metachromatic staining.
In mature rabbits, however, there was apparently no effect from FGF-2 in either group.
Conclusions: Application of FGF-2 facilitated cartilage repair in partial thickness defects in immature rabbits, but not in mature ones.
 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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International
Cartilage
Repair
SocietyIntroduction
Articular cartilage has a limited capacity for repair. Partial
thickness defects, which do not injure the subchondral
bones, do not heal spontaneously. A short-lived tissue
response has been reported, but it failed to provide sufﬁcient
cells and matrix to repair even small defects. In contrast, full
thickness defects, which extend beyond the subchondral
bone, receive an abundant source of mesenchymal cells for
affecting cartilage repair through the subchondral bone1.
However, the resulting repair tissue is predominantly of
a ﬁbrous nature, containing variable numbers of chondro-
cytes, ﬁbrocytes and an unorganized matrix. This ﬁbrocar-
tilage does not resemble the original cartilage either
biochemically or biomechanically and it ultimately deterio-
rates.
Several growth factors such as ﬁbroblast growth factor-2
(FGF-2)2e6, insulin-like growth factor-I (IGF-I)7e9, hepato-
cyte growth factor10, bonemorphogenetic protein-211,12, and
transforming growth factor-b2,13,14, have been exogenously
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Received 7 July 2003; revision accepted 9 April 2004.636applied to articular cartilage defects to potentially enhance
cartilage reconstitution. FGF-2 is widely distributed in
mesenchymal structures, mesoderm- and neuro-ectoderm-
derived cells. It is a member of a multi-lineage family that
binds to heparin. It acts as a potent mitogen in a wide variety
of cell types derived from mesoderm and neuro-ectoderm
in vitro15e17. The importance of FGF-2 in cartilage repair is
widely accepted.
In partial thickness defects, Cuevas et al. reported that
FGF-2 stimulated the proliferation of chondrocytes in
adolescent rabbits4, while Hunziker and Rosenberg did
not observe such effect in mature rabbits19. This difference
is possibly due to the age of the rabbits they used. Guerne
et al. showed age-related decline in chondrocyte response
to FGF-2 in vitro18. However, cartilage response to FGF-2
in vivo with increasing age is unclear. The purpose of this
study is to examine cartilage response to FGF-2 with
increasing age in vivo, using partial thickness defects in
immature and mature rabbits.
Materials and methods
Seventy-two Japanese white male rabbits (Japan Animals
Co. Ltd, Osaka, Japan) were used (36 immature rabbits and
36 adult rabbits). The average age of the immature rabbits
was approximately 12 weeks, and that of the mature rabbits
637Osteoarthritis and Cartilage Vol. 12, No. 8was approximately 24 weeks. The average weight of the
immature rabbits was approximately 2.3 kg, and that of the
mature rabbits was approximately 3.6 kg. The rabbits were
anesthetized by intramuscular injection of a mixture of
ketamine (100 mg/ml, 0.60e0.70 ml/kg body weight, SAN-
KYO Co. Ltd, Tokyo, Japan) and xylazine (20 mg/ml,
0.30 ml/kg body weight, BAYER Co. Ltd, Leverkusen,
Germany).
The skin around the knee was shaved anteriorly and
washed with 70% ethanol. A parapatellar medial approach
was used to expose the knee joint. The patella was
dislocated laterally. In principle, we made three longitudinal
partial thickness defects in the articular cartilage of the mid-
trochlear region of the femur with a round-shaped chisel.
However, the area of the mid-trochlear region was so small
that we could not occasionally avoid making only two
longitudinal partial thickness defects in some cases. Then,
the wound was closed. Partial thickness defects were made
in both knees. All rabbits were returned to their cages after
theoperation andwere allowed tomove freely.Noanimalwas
observed to have an abnormal gait or impaired locomotion.
We injected human recombinant FGF-2 (KAKEN PHARM.
Co. Ltd, Tokyo, Japan) into the articular cavity of the knees
through the lateral side of the patella ligament at the level of
the joint space. FGF-2 was injected eight times, immediately
after surgery and every 2 days for 2 weeks. A single dose of
FGF-2 was 10 ng/0.1 ml of saline, which was administered
to the FGF-2 (10 ng)-treated group, or 100 ng/0.1 ml of
saline, which was administered to the FGF-2 (100 ng)-
treated group. In the control group, 0.1 ml saline was injected
using the same time schedule.
At 2, 4, 8, 12, 24 and 48 weeks after surgery, respectively,
six rabbits were scheduled for sacriﬁce. Two immature
rabbits and one mature rabbit died before sacriﬁce.
Therefore, ﬁve immature rabbits were sacriﬁced at 8 and
12 weeks, and ﬁve mature rabbits at 48 weeks. The rest of
the rabbits were sacriﬁced as indicated in the time schedule.
The distal part of the femur was ﬁxed in 10% neutral-buffered
formalin (Wako Pure Chemicals Industries Co. Ltd, Osaka,
Japan) for 1 week, decalciﬁed with 0.5 M ethylenediamine-
tetraacetic acid (SIGMA Co. Ltd, St. Louis, MO, USA)
containing 0.1 M epsilon-amino-n-caproic acid (SIGMA Co.
Ltd) and 0.005 M benzamidine (SIGMA Co. Ltd), and
sectioned perpendicular to the defect. These sections were
obtained from the center of the defect. The specimens were
stained with toluidine blue and examined microscopically.
Partial thickness defects of articular cartilage are difﬁcult
to create. Although we conﬁrmed no breakage of the
subchondral bone in any histological sections, it is possible
that it happened in other planes. We had trained in creation
of partial thickness defects using a chisel, and no bleeding
was observed for any defect. If the subchondral bone had
been broken, the repair tissue in the defects would have
been macroscopically detected in the broken area. We did
not ﬁnd such tissue in any sample at any time point.
These sections were examined blindly and scored in-
dependently by two of the authors, without knowledge of the
group being examined, using a modiﬁed semiquantitative
scale for evaluating the histological appearance of repair
(Table I)20. The scale was composed of three categories with
a score range from 0 (best) to 9 (worst) points: ﬁlling of the
defect, matrix staining, and cell morphology. Whenever the
scores differed, the scorers discussed them and came to an
agreement.
The differences in the scores between the two FGF-
treated groups and the control group at various post-
operative times were tested using two-way factorial ANOVA,followed by the ManneWhitney U test for comparison.
Probability values less than 0.05 were considered signiﬁ-
cant. Stat View software (SAS Institute Inc., Cary, NC, USA)
was used for analysis.
Results
IMMATURE RABBITS
Histology
In the control group, cartilage repair was poor at 2, 4 and 8
weeks after surgery. Proliferation of chondrocytes on the
injured sites was observed slightly, but it was not adequate
to provide sufﬁcient cells and matrix to repair the defects.
At 12, 24 and 48 weeks, however, cartilage repair was
improved sequentially. In some cases, the repair tissue
showed some intense metachromatic staining, but defects
were ﬁlled only to half of the original depth in all cases
(Fig. 1).
In the FGF-2 (10 ng)-treated group, regenerative re-
sponse was poor at 2 weeks after surgery. At 4, 8 and 12
weeks, cartilage repair was superior to that of the control
group. However, there was no advance in repair at 24 and
48 weeks. At 48 weeks, the defects were ﬁlled with chon-
drocytes, but the center of the defect was concave and
metachromatic staining was less intense compared with the
surrounding cartilage (Fig. 2).
In the FGF-2 (100 ng)-treated group, cartilage repair was
poor at 2 weeks after surgery, similar to that of the other
groups. At 4 weeks, on the surface of the injured cartilage,
a few small masses of cells surrounded with intense
metachromatic matrix were observed. Then, at 8, 12, 24
and 48 weeks, the repair was improved sequentially. At
48 weeks, the defects were almost completely repaired
although the centers of the defects were slightly concave.
The repair tissue consisted of clusters of chondrocytes
and large amounts of extracellular matrix. The repair chon-
drocytes showed a round to polygonal morphology. Extra-
cellular matrix showed slightly less intense metachromatic
staining than the normal surrounding cartilage (Fig. 3).
Table I
The semiquantitative scale for grading the healing of articular
cartilage repair
(1) Filling of defect
A continuous
surface without depression
0
No or slight
depression, but a non-continuous surface
1
Depression of less
than 50% of the original defect
2
Depression of more
than 50% of the original defect
3
(2) Matrix staining
The same
as that of the adjacent tissue
0
Slightly decreased 1
Moderately decreased 2
No repair tissue 3
(3) Cell morphology
Chondrocytes of normal
appearance and density
0
Chondrocytes that
appeared normal but were hypocellular
1
Abnormal cells 2
An absence of cells 3
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The scores of the FGF-2 (100 ng)-treated group were
signiﬁcantly better than those of the control (P ¼ 0:002) and
FGF-2 (10 ng)-treated groups (P ¼ 0:009).
At 2 weeks after surgery, the scores were poor in each
group. At 4, 8, 12 weeks, the scores of the two FGF-2-
treated groups were improved sequentially. The scores of
the FGF-2 (100 ng)-treated group were signiﬁcantly better
than those of the control group at 8 weeks (P ¼ 0:028), and
better than those of the FGF-2 (10 ng)-treated group at 24
weeks (P ¼ 0:025). Finally, the scores of the FGF-2
(100 ng)-treated group were signiﬁcantly better than those
of the control (P ¼ 0:018) and the FGF-2 (10 ng)-treated
groups (P ¼ 0:019) at 48 weeks. However, there was no
signiﬁcant difference between the FGF-2 (10 ng)-treated
group and the control group at each postoperative time
point (Table II).
Fig. 1. Microscopic appearance of a perpendicular section of the
articular cartilage defect of the control group of the immature
rabbits. Toluidine blue staining, original magniﬁcation !40. The
arrows indicate the edges of the original defect. (A) The ﬁndings at
4 weeks; regenerative response rare. (B) The ﬁndings at 48 weeks;
the defect is ﬁlled with repair tissue, but the center of the defect is
concave and metachromatic staining is less intense compared with
that of the surrounding cartilage.MATURE RABBITS
Histology
In all groups, cartilage regeneration at the injured sites
was observed slightly, but regenerative response was too
poor to repair defects at each postoperative time point.
Some cases in the two FGF-2-treated groups showed
a decrease in metachromatic staining in uninjured chon-
drocytes. Neither cartilage thickening nor osteophyte
formation was seen (Fig. 4).
Histological score
Each group showed a smaller improvement of repair
sequentially compared to that of the immature rabbits.
Fig. 2. Microscopic appearance of a perpendicular section of the
articular cartilage defect of the FGF-2 (10 ng)-treated group of the
immature rabbits. Toluidine blue staining, original magniﬁcation
!40. The arrows indicate the edges of the original defect. (A) The
ﬁndings at 4 weeks; although a few small masses of cells
surrounded with intense metachromatic matrix are observed,
cartilage repair is poor. (B) The ﬁndings at 48 weeks; the defects
are ﬁlled with repair tissue, but the center of the defect is concave
and the articular surface is not continuous. Metachromatic staining
is less intense compared with that of surrounding cartilage.
639Osteoarthritis and Cartilage Vol. 12, No. 8However, there were no signiﬁcant differences in the scores
between the two FGF-2-treated groups and the control
group at each postoperative time point (Table III).
Discussion
The present study showed that the application of FGF-2
facilitated cartilage repair in partial thickness defects in
immature rabbits, but not in mature rabbits. In the FGF-2
(100 ng)-treated group of immature rabbits, cartilage repair
improved sequentially, and was signiﬁcantly better than that
of the other groups at 48 weeks. The repair tissue consisted
Fig. 3. Microscopic appearance of a perpendicular section of the
articular cartilage defect of the FGF-2 (100 ng)-treated group of the
immature rabbits. Toluidine blue staining, original magniﬁcation
!40. The arrows indicate the edges of the original defect. (A) The
ﬁndings at 4 weeks; although a few small masses of cells surrounded
with intense metachromatic matrix are observed, cartilage repair is
poor. (B) The ﬁndings at 48 weeks; although the center of the defect
is slightly concave, the defect is almost completely repaired. The
repair tissue consists of clusters of chondrocytes and large amounts
of extracellular matrix. The repair chondrocytes show a round to
polygonal morphology. The extracellular matrix shows a slightly less
intense metachromatic staining than that of the normal surrounding
cartilage.of clusters of chondrocytes which showed a round to
polygonal morphology, and large amounts of extracellular
matrix which showed intense metachromatic staining. In the
mature rabbits, however, there were no signiﬁcant differ-
ences in cartilage repair between the two FGF-2-treated
groups and the control group. At 48 weeks, proliferation of
chondrocytes at the injured sites was too poor to ﬁll the
defects in any groups.
In partial thickness defects, Cuevas et al. administered
a large dose of FGF-2 to stimulate chondrocyte proliferation
in an adolescent rabbit model. At 20 days after surgery, the
experimental group showed excellent cartilage repair
compared with the saline-treated group4. In contrast,
Hunziker and Rosenberg reported that FGF-2 did not
promote chondrocyte proliferation in mature rabbits19. This
difference is possibly due to the age of the rabbits they
used. It is generally accepted that, with increasing age,
chondrocytes synthesize smaller, less uniform aggrecan
molecules and less functional link protein, their mitotic and
synthetic activity declines, and their response to anabolic
mechanical stimuli and growth factors decreases. This was
supported by Martin and Buckwalter, who measured cell
senescence markers in human articular cartilage21. In
addition, they also reported age-related decline in chon-
drocyte response to IGF-I in vitro22. Concerning FGF-2,
Guerne et al. showed age-related decline in chondrocyte
response to FGF-2 in vitro18. However, cartilage response
to FGF-2 in vivo with increasing age is unclear. We
demonstrated that, in immature rabbits, FGF-2 produced
signiﬁcantly better repair than that produced by the same
treatment in mature rabbits. This result suggested that there
was a difference in the response of cartilage to FGF-2 with
age in vivo. Although the mechanism is unknown at
present, we hypothesize that expression of FGF receptors
might be stronger in immature rabbits or that the intense
matrix around cells in mature rabbits might disturb the
proliferation of cells.
In full thickness defects, mesenchymal cells, which are
considered to be progenitor cells for chondrocytes in bone
marrow, have an important role in cartilage repair1,20. It has
been reported that FGF-2 stimulated cartilage repair in full
thickness defects of articular cartilage in mature rabbits5,6.
These results suggest that FGF-2 could inﬂuence not only
the chondrocytes themselves, but also the mesenchymal
cells, in full thickness defects of mature rabbits. However,
Table II
Mean and standard deviation of the scores of the histological
grading of repair in immature rabbits
2
4
8
12
24
48
*
*
*
*
*
*
*
6.94    0.98
(N=9)
7.18    1.22
(N=8)
7.40    1.24
(N=8)
5.60    1.71
(N=5)
5.42    1.51
(N=8)
5.42    1.09
(N=8)
7.00    0.47
(N=8)
6.50    1.225
(N=10)
5.56    1.74
(N=8)
5.35    0.88
(N=10)
5.75    1.21
(N=12)
5.27    0.90
(N=11)
6.90    0.96
(N=10)
6.00    1.22
(N=11)
4.91    1.93
(N=6)
4.68    1.27
(N=10)
4.27    1.42
(N=11)
4.00    1.28
(N=8)
Potoperative
periods (weeks)
The score of the
control group
The score of the
FGF(10 ng)-treated
group
The score of the
FGF(100 ng)-treated
group
N, number of defects estimated, P!0:05.
640 T. Yamamoto et al.: Cartilage response to (FGF-2) in rabbitsFig. 4. Microscopic appearance of a perpendicular section of the articular cartilage defect at 48 weeks in mature rabbits. Toluidine blue staining
!40. The arrows indicate the edges of the original defect. (A) The control group, (B) the FGF-2 (10 ng)-treated group, and (C) the FGF-2
(100 ng)-treated group: proliferation of chondrocytes at the injured sites is observed, but the regenerative response is inadequate to provide
sufﬁcient cells and matrix to ﬁll the defects.as shown in this study, FGF-2 is capable of stimulating
proliferation of chondrocytes, although this was conﬁned to
chondrocytes of immature rabbits.
Shida et al. reported that a single injection of FGF-2 into
a rat joint stimulates articular cartilage and the subsequent
osteophyte formation. They found that chondrocytes in the
normal articular cartilage responded, but immature cells,
such as periosteal cells at the edge of the femoral condyle,responded more and differentiated cartilage. Then, the
thickened cartilage became bone23. Although we found no
cartilage thickening, synovial proliferation or osteophyte
formation, some cases in the FGF-2-treated groups showed
a decrease in metachromatic staining in uninjured chon-
drocytes (data not shown). The acceptable dose should be
identiﬁed in humans to prevent causing the degenerative
change of cartilage.Table III
Mean and standard deviation of the scores of the histological grading of repair in mature rabbits
Postoperative
periods (weeks)
The score of the
control group
The score of the
FGF(10 ng)-treated group
The score of the
FGF(100 ng)-treated group
2 8.36G0.50 (N ¼ 11) 8.33G0.65 (N ¼ 12) 7.81G0.98 (N ¼ 11)
4 7.50G1.31 (N ¼ 12) 8.20G0.78 (N ¼ 10) 7.90G1.37 (N ¼ 11)
8 7.44G1.33 (N ¼ 9) 7.33G1.11 (N ¼ 9) 7.45G0.82 (N ¼ 11)
12 7.75G1.05 (N ¼ 12) 7.25G1.42 (N ¼ 12) 7.09G1.86 (N ¼ 11)
24 7.00G2.17 (N ¼ 9) 7.08G1.16 (N ¼ 12) 7.25G1.21 (N ¼ 12)
48 7.00G1.41 (N ¼ 6) 6.66G1.43 (N ¼ 12) 6.87G1.24 (N ¼ 8)
N, number of defects estimated.
641Osteoarthritis and Cartilage Vol. 12, No. 8Many growth factors affect chondrogenesis and cartilage
repair. If a growth factor has an adequate effect on cartilage
repair, it would be preferred clinically, because these factors
are much easier to use than transplantation24e26.
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